Hexavest’s Zimmer Biomet ZBH Stock Holding History

Hexavest’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-29	Closed	-$4K	–	442
2018 Q3	$4K	Sell	29 -4,672	-99%	-$556K	﹤0.01%	423
2018 Q2	$509K	Sell	4,701 -485,046	-99%	-$52.8M	0.01%	236
2018 Q1	$51.8M	Buy	489,747 +162,976	+50%	+$18.9M	0.65%	47
2017 Q4	$38.3M	Buy	326,771 +9,382	+3%	+$1.06M	0.44%	76
2017 Q3	$36.1M	Buy	317,389 +7,859	+3%	+$907K	0.44%	71
2017 Q2	$38.6M	Sell	309,530 -11,022	-3%	-$1.31M	0.5%	66
2017 Q1	$38M	Buy	+320,552	New	+$36.3M	0.45%	73

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hexavest's ZBH Position: Q4 2018 in Review

Hexavest sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 29 shares — an estimated $4K sold.

Hexavest first reported a position in ZBH in Q1 2017 and held it in 7 quarters. The position peaked at $51.8M in Q1 2018. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Hexavest reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Hexavest sold 29 Zimmer Biomet shares in Q4 2018, an estimated $4K.
Hexavest first reported a position in Zimmer Biomet in Q1 2017 and held it in 7 quarters.
Hexavest's Zimmer Biomet position peaked at $51.8M in Q1 2018.
871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Hexavest's 13F filing for Q4 2018, filed 10 Jan 2019.